25.10.2021
•
News
M&A
Ostrava-based EKOVA ELECTRIC Becomes Part of ŠKODA TRANSPORTATION
In 2020, KŠB started advising ŠKODA TRANSPORTATION a.s. on the acquisition of a 100% stake in EKOVA ELECTRIC a.s., an Ostrava-based company engaged in manufacturing, upgrading and servicing trams, trolleybuses and electric buses (more information here).
This year, KŠB’s team (Petr Kasík, Jakub Porod and Ota Mach) helped complete the transaction as the shares previously held by Dopravní podnik Ostrava were transferred and the transaction settled in August 2021.
EKOVA ELECTRIC a.s. (under new name ŠKODA EKOVA a.s.) will focus on servicing, upgrading and repairing public transport vehicles and on manufacturing trams for the City of Ostrava. Further details are available here.
Other articles
8.7.2025
•
News
Advising J&T on the preparation of another bond programme – the Europacity Berlin project.
KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
•
News
A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein
Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
•
News
KŠB advised the seller on the sale of mcePharma to the Brenntag Group
The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.
